Amarin Shares Surge After $175M European Licensing Deal For Heart Drug VAZKEPA

benzinga.com/trading-ideas/movers/25/06/46080684/amarin-shares-surge-after-175m-european-licensing-deal-for-heart-drug-vazkepa

Amarin Corporation (NASDAQ:AMRN) shares are trading higher Tuesday after the company announced a long-term exclusive license and supply agreement with Recordati S.p.A. to commercialize its cardiovascular drug VAZKEPA (icosapent ethyl) across 59 countries in Europe.
What To Know: Under…

This story appeared on benzinga.com, 2025-06-24 18:02:32.
The Entire Business World on a Single Page. Free to Use →